Skip to main content
. 2026 Jul 13;17:1893876. doi: 10.3389/fendo.2026.1893876

Figure 3.

Two-panel data visualization compares odds ratio (OR, panel A) and hazard ratio (HR, panel B) versus adropin levels with 95 percent confidence intervals, showing significant overall associations (p<0.001) and indicating non-linear association for HR (p=0.0035) but not OR (p=0.3069); a vertical dashed line marks adropin at approximately 5.2 in both panels.

RCS analyses of the association between serum adropin and DKD. (A) RCS analysis of the cross-sectional dose–response association between serum adropin and prevalent DKD. (B) RCS analysis of the longitudinal dose–response association between serum adropin and incident DKD. Solid lines represent adjusted estimates and shaded areas indicate 95% CIs. The vertical dashed line denotes the reference value of serum adropin. Models were adjusted for age, sex, BMI, smoking status, alcohol consumption, hypertension and medication use.